Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 20.04.2026 2 AIDS 1 AIDS Res Hum Retroviruses 2 Am J Epidemiol 1 Ann Intern Med 2 Antimicrob Agents Chemother 1 BMC Cancer 1 BMJ 1 Br J Haematol 8 Clin Infect Dis 6 HIV Med 1 Int J Cancer 10 J Acquir Immune Defic Syndr 1 J Immunol 6 J Infect Dis 3 J Med Virol 1 PLoS Med 5 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. READY EA, Patterson C, Gibbons S, Yoong D, et al
   Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug-drug interactions (ACCURATE-DDI).
   AIDS. 2026 Apr 13. doi: 10.1097/QAD.0000000000004522.
   PubMed         Abstract available
   
   
2. DURAN RAMIREZ JJ, Kouyos RD, Abela I, Beguelin C, et al
   Improving cohort coverage estimation using a data triangulation framework: the Swiss HIV Cohort Study example.
   AIDS. 2026 Apr 10. doi: 10.1097/QAD.0000000000004523.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

3. LEE D, Brawley S, Hayward B, Mari E, et al
   Revisiting HIV-Associated Wasting: Results from a U.S. Cross-Sectional Survey of Health Care Providers' Knowledge, Attitude, and Current Practices.
   AIDS Res Hum Retroviruses. 2026 Apr 11:8892229261437509.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

4. HAW NJL, Hogan B, Humes E, Coburn SB, et al
   New to Cohort, Not New to Care: Leveraging Historical Data in HIV Clinical Cohorts in the United States.
   Am J Epidemiol. 2026 Apr 13:kwag082. doi: 10.1093.
   PubMed         Abstract available
   
   
5. ZHU L, Havens JR, Rudolph AE, Young AM, et al
   Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation (AJE-00824-2024).
   Am J Epidemiol. 2025 Mar 10:kwaf052. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

6. ALBALOUL H, Nemer A, Saini N, Schuster MG, et al
   Infectious Diseases: What You May Have Missed in 2025.
   Ann Intern Med. 2026 Apr 14:e2600983. doi: 10.7326/ANNALS-26-00983.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

7. MOSCHESE D, Fusetti C, Lazzarin S, Giacomelli A, et al
   Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.
   Antimicrob Agents Chemother. 2026 Apr 15:e0016526. doi: 10.1128/aac.00165.
   PubMed         Abstract available
   
   
8. GERLOVINA I, Berube S, Briggs J, Murie K, et al
   Classification of outcomes in antimalarial therapeutic efficacy studies with Aster.
   Antimicrob Agents Chemother. 2026 Apr 13:e0141125. doi: 10.1128/aac.01411.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. SORI DA, Ali R, Jibat N, Adissu W, et al
   Clinicopathologic characteristics and predictors of treatment uptake among patients with cervical cancer managed at Jimma University Medical Center, Southwest Ethiopia.
   BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15987.
   PubMed        
   
   

   
   BMJ

10. YUSUFZAI A
    HIV: "At least" 329 children infected in Pakistan province, as medical association blames negligence.
    BMJ. 2026;393:s734.
    PubMed        
    
    

    
    Br J Haematol

11. OKSENHENDLER E, Malphettes M, Meignin V, Boutboul D, et al
    Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country.
    Br J Haematol. 2026 Apr 13. doi: 10.1111/bjh.70480.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

12. MCGEE-AVILA JK, Haas CB, Shing JZ, Lawrence WR, et al
    Hepatocellular Carcinoma Survival in People With and Without HIV in the United States, 2001-2019.
    Clin Infect Dis. 2026 Apr 9:ciag137. doi: 10.1093.
    PubMed         Abstract available
    
    
13. FLETCHER FE, Pertuit OR, Troisi C, Kerr J, et al
    Tracking HIV Through Wastewater: Ethical Considerations in Public Health Surveillance.
    Clin Infect Dis. 2026 Apr 9:ciag241. doi: 10.1093.
    PubMed         Abstract available
    
    
14. WYNCOLL J, Kamolrattana R, Archary M, Mujuru HA, et al
    Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.
    Clin Infect Dis. 2026 Apr 10:ciag232. doi: 10.1093.
    PubMed         Abstract available
    
    
15. PALUMBO P
    You've Come a Long Way Baby-but Many Miles Left to Go.
    Clin Infect Dis. 2026 Apr 10:ciag233. doi: 10.1093.
    PubMed        
    
    
16. BENGTSON A
    High levels of elevated blood pressure among pregnant and postpartum women with HIV, regardless of dolutegravir initiation.
    Clin Infect Dis. 2026 Apr 13:ciag246. doi: 10.1093.
    PubMed        
    
    
17. HOFFMAN R, Brummel S, Pinilla M, Malonga G, et al
    Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV.
    Clin Infect Dis. 2026 Apr 13:ciag245. doi: 10.1093.
    PubMed         Abstract available
    
    
18. ZHAN S, Liu W, Yang L, Chen Z, et al
    Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.
    Clin Infect Dis. 2026 Apr 13:ciag247. doi: 10.1093.
    PubMed         Abstract available
    
    
19. HERRERO JI, Aguero F, Manzardo C, Gastaca M, et al
    De Novo Cancer in Liver Transplant Patients With Human Immunodeficiency Virus Infection: A Multicenter Nationwide Cohort Study.
    Clin Infect Dis. 2026 Apr 16:ciag124. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

20. RUSSO A, Giacomelli A, De Vito A, Mazzitelli M, et al
    Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres.
    HIV Med. 2026 Apr 11. doi: 10.1111/hiv.70241.
    PubMed        
    
    
21. MILIC J, Pugliese A, Belli M, Lonardi GL, et al
    A multidisciplinary, AI-supported quality improvement intervention to manage polypharmacy in aging people with HIV.
    HIV Med. 2026 Apr 11. doi: 10.1111/hiv.70234.
    PubMed         Abstract available
    
    
22. HENALES IRUZUBIETA I, Romero Marin G, Patron Hernandez MA, Perez Stachowski J, et al
    Impact of the COVID-19 pandemic on missed opportunities for diagnosis of HIV infection: HUCS-ODIPER (missed diagnostic opportunities) study.
    HIV Med. 2026 Apr 14. doi: 10.1111/hiv.70243.
    PubMed         Abstract available
    
    
23. HENDERSON M, Dutey-Magni P, Herrera C, Stohr W, et al
    Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART.
    HIV Med. 2026 Apr 16. doi: 10.1111/hiv.70236.
    PubMed         Abstract available
    
    
24. FOX D, Slim J, Overton ET, Doblado-Maldonado A, et al
    Efficacy of dolutegravir/lamivudine in adults with HIV-1 and isolated reactive hepatitis B core antibody: Insights from Phase 3/3b study results.
    HIV Med. 2026 Apr 16. doi: 10.1111/hiv.70237.
    PubMed         Abstract available
    
    
25. RACCAGNI AR, Lolatto R, Capra N, Loi G, et al
    Three settings, one goal: Performance of different HIV testing strategies at a tertiary centre in Milan.
    HIV Med. 2026 Apr 18. doi: 10.1111/hiv.70242.
    PubMed         Abstract available
    
    

    
    Int J Cancer

26. PELLEGRINO RA, Shepherd BE, Pujari S, Fink V, et al
    Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium.
    Int J Cancer. 2026 Apr 16. doi: 10.1002/ijc.70503.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

27. AL-ANI R, Williams PL, Lee J, Kacanek D, et al
    Sleep Quality by Reproductive Stage among Women Living with HIV in the United States Enrolled in the Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) Study.
    J Acquir Immune Defic Syndr. 2026 Apr 10:10.1097/QAI.0000000000003856.
    PubMed         Abstract available
    
    
28. WU Q, Karim S, Van MT, Enns B, et al
    Impact of COVID-19 on late HIV diagnosis rates by race/ethnicity in Ending the HIV Epidemic (EHE) priority jurisdictions in the United States.
    J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003888.
    PubMed         Abstract available
    
    
29. EDUN O, Okell L, Wolock TM, Korenromp EL, et al
    Validating HIV viral suppression threshold adjustments for comparable estimates using data from nationally representative household surveys in sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003878.
    PubMed         Abstract available
    
    
30. MCCORMICK LJ, Gillot M, Ussery F, Bihini C, et al
    Cervical cancer screening coverage increased in Malawi, Tanzania, Zambia, and Zimbabwe: Findings from sequential Population-based HIV Impact Assessment Surveys 2015-2017 and 2020-2023.
    J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003880.
    PubMed         Abstract available
    
    
31. RHODES AG, Jarris DK, Walker C, Drezner K, et al
    Using the ATra Black Box for near real-time depiction of the HIV Continuum of Care in the Ryan White DC Eligible Metropolitan Area.
    J Acquir Immune Defic Syndr. 2026 Apr 13. doi: 10.1097/QAI.0000000000003886.
    PubMed         Abstract available
    
    
32. HOAGLAND B, Torres TS, Konda K, Moreira RI, et al
    HIV self-testing and coupons distribution by persons using PrEP to create demand for combination HIV prevention services among men who have sex with men (MSM) and transgender women: a randomized clinical trial in the context of the ImPrEP project.
    J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003887.
    PubMed         Abstract available
    
    
33. WILLIAMS R, Heise MJ, Carrico AW, Duncan DT, et al
    Associations Between Intersectional Discrimination and HIV Viral Suppression: Examining Indirect Pathways Through Mental Health, Substance Use, Stress, and Social Support among Sexual Minoritized Men Living with HIV.
    J Acquir Immune Defic Syndr. 2026 Apr 17. doi: 10.1097/QAI.0000000000003890.
    PubMed         Abstract available
    
    
34. HAMILL MM, Gunaratne MP, McFall AM, Iqbal HS, et al
    Increasing Syphilis Prevalence Among MSM Across India Despite Improvements in the HIV Care Continuum.
    J Acquir Immune Defic Syndr. 2026 Apr 17. doi: 10.1097/QAI.0000000000003860.
    PubMed         Abstract available
    
    
35. CORDIE A, Kamel AM, Mohamed R, Ebrahim SM, et al
    Diagnostic Performance of Fatty Liver Index for Hepatic Steatosis and its Association With Fibrosis in People Living With HIV.
    J Acquir Immune Defic Syndr. 2026;101:547-554.
    PubMed         Abstract available
    
    
36. SUTEETAMRONG S, Vasikasin V, Apiyangkool T, Kanjanavithayakul Y, et al
    Clinical Outcomes of Immune Nonresponse Among Virally Suppressed Adults Living with HIV in Thailand.
    J Acquir Immune Defic Syndr. 2026 Apr 10. doi: 10.1097/QAI.0000000000003881.
    PubMed         Abstract available
    
    

    
    J Immunol

37. SANDSTROM K, Anderson JL, Katz JE, Wetzel M, et al
    Modulation of rhesus macaque killer cell immunoglobulin-like receptor-MHC I interactions by simian immunodeficiency virus peptides.
    J Immunol. 2026;215:vkag053.
    PubMed         Abstract available
    
    

    
    J Infect Dis

38. ISNARD S, Royston L, Berini CA, Mabanga T, et al
    Plasma GDF-15 levels are associated with HIV reservoir markers independently of inflammation in people with HIV on antiretroviral therapy.
    J Infect Dis. 2026 Apr 9:jiag202. doi: 10.1093.
    PubMed         Abstract available
    
    
39. JARAMILLO-UNDERWOOD A, Ogunniyi A, Zhou H, Uhomoibhi P, et al
    Risk factors and geospatial associations with Plasmodium falciparum malaria infection and IgG seroprevalence: Nigeria, 2018.
    J Infect Dis. 2026 Apr 8:jiag098. doi: 10.1093.
    PubMed         Abstract available
    
    
40. WARRIER L, Saito A, Graham JB, Swarts JL, et al
    Initiation of oral pre-exposure prophylaxis associated with changes in genital tract T cell phenotypes in women exposed to HIV.
    J Infect Dis. 2026 Apr 9:jiag204. doi: 10.1093.
    PubMed         Abstract available
    
    
41. WONG A, Aung HL, Varma R, Templeton DJ, et al
    Asymptomatic screening for Neisseria gonorrhoeae among gay and bisexual men attending public sexual health services in Australia and associations with patterns of ceftriaxone consumption: a retrospective observational study.
    J Infect Dis. 2026 Apr 9:jiag192. doi: 10.1093.
    PubMed         Abstract available
    
    
42. EVANS C, Chandna J, Mutasa K, Rukobo S, et al
    Neurodevelopment in children exposed to antenatal CMV viraemia in a high HIV prevalence area.
    J Infect Dis. 2026 Apr 9:jiag214. doi: 10.1093.
    PubMed         Abstract available
    
    
43. GHANEM M, Srivastava R, Ektefaie Y, Hoppes D, et al
    Tuberculosis Disease Severity Assessment Using Clinical Variables and Radiology Enabled by Artificial Intelligence.
    J Infect Dis. 2026 Apr 16:jiag149. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

44. GUIMARAES ACS, Rodrigues LLS, Campos LB, Martinelli KG, et al
    Beyond Human Papillomavirus (HPV): Detection of EBV and Polyomaviruses in Cervical and Anal Samples.
    J Med Virol. 2026;98:e70909.
    PubMed         Abstract available
    
    
45. POISSON L, Hingrat QL, Lermechain F, Tombette F, et al
    HIV-1 Non Group-M Phenotypic Susceptibility to Ibalizumab.
    J Med Virol. 2026;98:e70911.
    PubMed         Abstract available
    
    
46. GAO L, Cao D, Tao W, Zhang D, et al
    Quercetin Interrupts the SIRT3/ROS/NF-kappaB/SPI1 Feedback Loop to Ameliorate Microglia-Mediated HIV-1 Tat Neurotoxicity.
    J Med Virol. 2026;98:e70906.
    PubMed         Abstract available
    
    

    
    PLoS Med

47. TIEOSAPJAROEN W, Williams E, Johnson CC, Baptista Da Silva C, et al
    Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review.
    PLoS Med. 2026;23:e1005030.
    PubMed         Abstract available
    
    

    
    PLoS One

48. WALDERICH SJ, Fitzpatrick-Collins J, Bates A, Zhang MH, et al
    Recurrent episodes of pneumonia are associated with worse lung function in people with HIV.
    PLoS One. 2026;21:e0344756.
    PubMed         Abstract available
    
    
49. MENGISTIE BA, Aragaw GM, Mulatu GG, Wondie KY, et al
    Virologic suppression among HIV-positive pregnant and lactating women receiving antiretroviral therapy in Africa: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0346045.
    PubMed         Abstract available
    
    
50. ZURASHVILI T, Kajaia M, Akeju O, DeHovitz J, et al
    Barriers and facilitators to condom use among People Who Inject Drugs in Georgia: A qualitative study guided by the COM-B model.
    PLoS One. 2026;21:e0346771.
    PubMed         Abstract available
    
    
51. SIMEGN MB, Geremew H, Chinkey FD, Alemneh ZT, et al
    Inconsistent condom use and its associated factors among female sex workers in African countries: Systematic review and meta-analysis.
    PLoS One. 2026;21:e0346903.
    PubMed         Abstract available
    
    
52. ASOGWA CC, Aniaku SE, Ezugorie OMJ, Mbah E, et al
    Mathematical Model on the optimal control of HIV/AIDS transmission dynamics, incorporating the uninfected class after an effective exposure to the disease.
    PLoS One. 2026;21:e0346773.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

53. ROMERO EV, Clyde AE, Giorgi EE, Westfall DH, et al
    Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo.
    Proc Natl Acad Sci U S A. 2026;123:e2524021123.
    PubMed         Abstract available
    
    

    
    Science

54. HARTWEGER H, Ruprecht C, Yao KH, Laffont P, et al
    B lymphocyte protein factories produced by hematopoietic stem cell gene editing.
    Science. 2026;392:eadz8994.
    PubMed         Abstract available
    
    

    
    Vaccine

55. KAPELUS DJ, Ranchod H, Olwagen CP, Koen A, et al
    Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study.
    Vaccine. 2026;81:128580.
    PubMed         Abstract available
    
    
56. MEHTA UC, Gomba Y, Salie I, Welte A, et al
    Knowledge, perceptions, and practices of healthcare workers on surveillance of adverse events following maternal immunisation in South Africa.
    Vaccine. 2026;81:128557.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum